ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag federal funding microbiology evolution

Monitoring Mutations with Microfluidics
Ruth Williams | Mar 15, 2018 | 3 min read
A device dubbed the “mother machine” enables real-time observation of mutagenesis in single bacterial cells.  
Of Cells and Limits
Anna Azvolinsky | Mar 1, 2015 | 9 min read
Leonard Hayflick has been unafraid to speak his mind, whether it is to upend a well-entrenched dogma or to challenge the federal government. At 86, he’s nowhere near retirement.
Hot-Vent Microbes: Looking Backward In Evolution For Future Uses
Myrna Watanabe | May 29, 1994 | 7 min read
They live--thrive, even--in boiling water! They feed on sulfur or hydrogen. They could be from one of the moons of Jupiter. In fact, their existence here on Earth has led scientists to realize that planets they hitherto assumed to be lifeless might support life. These thermophilic, or heat- loving, microbes--Archaea--are attracting a small but growing cadre of researchers and serious research funding from the United States governmen
Hot-Vent Microbes: Looking Backward In Evolution For Future Uses
Myrna Watanabe | May 29, 1994 | 7 min read
They live--thrive, even--in boiling water! They feed on sulfur or hydrogen. They could be from one of the moons of Jupiter. In fact, their existence here on Earth has led scientists to realize that planets they hitherto assumed to be lifeless might support life. These thermophilic, or heat- loving, microbes--Archaea--are attracting a small but growing cadre of researchers and serious research funding from the United States governmen
Updated Sept 1
coronavirus pandemic news articles covid-19 sars-cov-2 virology research science
Follow the Coronavirus Outbreak
The Scientist | Feb 20, 2020 | 10+ min read
Saliva tests screen staff and students at University of Illinois; Study ranks species most susceptible to SARS-CoV-2 infection; COVID-19 clinical trials test drugs that inhibit kinin system
Bioterrorism Research: New Money, New Anxieties
John Dudley Miller | Apr 6, 2003 | 8 min read
Ned Shaw US scientists have reason to feel both heady and scared. The federal government recently released unprecedented billions of dollars to fund bioterrorism research. Yet, the merits of this sudden shift in focus are being debated, and some worry that the money will be squandered or wasted. "I have been really very upset by the focus on bioterrorism," says Stanley Falkow, professor of microbiology and immunology and of medicine at Stanford University. "Everybody's talking about it, but th
NIH Director Francis Collins receiving his first dose of the Moderna COVID-19 vaccine on December 2020.
Francis Collins to Retire as NIH Director by Year’s End
Christie Wilcox, PhD | Oct 5, 2021 | 3 min read
Collins has announced his intent to step down after leading the National Institutes of Health for more than 12 years.
Notebook
The Scientist Staff | Jul 7, 1996 | 7 min read
On June 14, a House Appropriations subcommittee gave some researchers cause for celebration when it surprisingly voted to remove a provision in a government spending bill that extended a ban on federal funding of human embryo research. However, their glee was short-lived. The full panel turned around on June 25 and adopted an amendment to continue the research ban. John Eppig, senior staff scientist at Jackson Laboratory in Bar Harbor, Maine, doubts that the ban will be overturned anytime soon,
Genome Investigator Craig Venter Reflects On Turbulent Past And Future Ambitions
Karen Young Kreeger | Jul 23, 1995 | 8 min read
And Future Ambitions Editor's Note: For the past four years, former National Institutes of Health researcher J. Craig Venter has been a major figure in the turbulent debates and scientific discoveries surrounding the study of genes and genomes. Events heated up in 1991, when NIH attempted to patent gene fragments, which were isolated using Venter's expressed sequence tag (EST)/complementary DNA (cDNA) approach for discovering human genes (M.A. Adams et al., Science, 252:1651-6, 1991). NIH's mo
Smaller Is Often Better For Scientific Meetings, Researchers Report
Ricki Lewis | Apr 16, 1995 | 7 min read
Despite travel-budget cuts at many institutions and companies, as well as the growing number of gatherings on the annual calendar, attendance at many scientific meetings remains strong. But researchers are becoming choosier in deciding which conferences they will attend, more carefully weighing the expense--in both money and time spent away from the lab--against the expected scientific and career-building returns. Kenneth I. Berns, president-elect of the American Society for Microbiology (ASM),

Run a Search

ADVERTISEMENT